Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lynch

Showing results (801-810 of 1,195) with videos related to

Pageof 120
Sort By:
The American Journal on Addictions|September 25, 2014
A pilot trial of injectable, extended-release naltrexone for the treatment of co-occurring cocaine and alcohol dependenceHelen M Pettinati, Kyle M Kampman, Kevin G Lynch, et al.
The Journal of Surgical Research|July 9, 1998
Hospital-wide educational program decreases red blood cell transfusionsJ P Rehm, P S Otto, W W West, et al.
Irish Medical Journal|March 1, 1991
Laparoscopic cholecystectomy: a hundred consecutive casesP Grace, A Quereshi, A Darzi, et al.
Journal of General Internal Medicine|September 21, 2013
A randomized clinical trial of alcohol care management delivered in Department of Veterans Affairs primary care clinics versus specialty addiction treatmentDavid W Oslin, Kevin G Lynch, Stephen A Maisto, et al.
Alcoholism, Clinical and Experimental Research|October 24, 2002
Carbohydrate-deficient transferrin levels reflect heavy drinking in alcohol-dependent women seeking treatmentMargaret R Rukstalis, Kevin G Lynch, David W Oslin, et al.
Biological Psychiatry|January 4, 2016
The Selective Serotonin Reuptake Inhibitor Citalopram Decreases Human Immunodeficiency Virus Receptor and Coreceptor Expression in Immune CellsJeffrey M Greeson, David R Gettes, Sergei Spitsin, et al.
The International Journal of Neuropsychopharmacology|January 29, 2019
Behavioral and Accumbal Responses During an Affective Go/No-Go Task Predict Adherence to Injectable Naltrexone Treatment in Opioid Use DisorderZhenhao Shi, Kanchana Jagannathan, An-Li Wang, et al.
Psychopharmacology|September 9, 2006
Association of OPRM1 A118G variant with the relative reinforcing value of nicotineR Ray, C Jepson, F Patterson, et al.
Addiction Research & Theory|September 27, 2016
Treatment choices and subsequent attendance by substance-dependent patients who disengage from intensive outpatient treatmentDeborah H A Van Horn, Michelle Drapkin, Kevin G Lynch, et al.
Molecular Psychiatry|March 14, 2012
Impairment of synaptic plasticity by the stress mediator CRH involves selective destruction of thin dendritic spines via RhoA signalingY Chen, E A Kramár, L Y Chen, et al.
Pageof 120

Showing results (801-810 of 1,195) with videos related to

Sort By:
Pageof 120
The American Journal on Addictions|September 25, 2014
A pilot trial of injectable, extended-release naltrexone for the treatment of co-occurring cocaine and alcohol dependenceHelen M Pettinati, Kyle M Kampman, Kevin G Lynch, et al.
The Journal of Surgical Research|July 9, 1998
Hospital-wide educational program decreases red blood cell transfusionsJ P Rehm, P S Otto, W W West, et al.
Irish Medical Journal|March 1, 1991
Laparoscopic cholecystectomy: a hundred consecutive casesP Grace, A Quereshi, A Darzi, et al.
Journal of General Internal Medicine|September 21, 2013
A randomized clinical trial of alcohol care management delivered in Department of Veterans Affairs primary care clinics versus specialty addiction treatmentDavid W Oslin, Kevin G Lynch, Stephen A Maisto, et al.
Alcoholism, Clinical and Experimental Research|October 24, 2002
Carbohydrate-deficient transferrin levels reflect heavy drinking in alcohol-dependent women seeking treatmentMargaret R Rukstalis, Kevin G Lynch, David W Oslin, et al.
Biological Psychiatry|January 4, 2016
The Selective Serotonin Reuptake Inhibitor Citalopram Decreases Human Immunodeficiency Virus Receptor and Coreceptor Expression in Immune CellsJeffrey M Greeson, David R Gettes, Sergei Spitsin, et al.
The International Journal of Neuropsychopharmacology|January 29, 2019
Behavioral and Accumbal Responses During an Affective Go/No-Go Task Predict Adherence to Injectable Naltrexone Treatment in Opioid Use DisorderZhenhao Shi, Kanchana Jagannathan, An-Li Wang, et al.
Psychopharmacology|September 9, 2006
Association of OPRM1 A118G variant with the relative reinforcing value of nicotineR Ray, C Jepson, F Patterson, et al.
Addiction Research & Theory|September 27, 2016
Treatment choices and subsequent attendance by substance-dependent patients who disengage from intensive outpatient treatmentDeborah H A Van Horn, Michelle Drapkin, Kevin G Lynch, et al.
Molecular Psychiatry|March 14, 2012
Impairment of synaptic plasticity by the stress mediator CRH involves selective destruction of thin dendritic spines via RhoA signalingY Chen, E A Kramár, L Y Chen, et al.
Pageof 120